Comparison of the Diagnostic Accuracy: US-guided Percutaneous Lung Biopsies vs CT-guided in Peripheral Lung Lesions
Recruiting
N/A
Interventional Study
Peripheral Lung Lesions
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 236 (estimated)
- Sponsor
- University Hospital of Ferrara · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A non-sponsored prospective randomized single-blind national multicenter interventional study which aims to compare the diagnostic accuracy between US-guided percutaneous lung needle biopsies and CT-guided in peripheral lung lesions. Secondary endpoints are:
* onset of number and type of complications during and after the procedure, within the first three hour;
* exposition to ionizing radiation,…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Willingness and ability to provide free and informed consent. Age older then 18 years old.
* Peripheric pulmonary lesions adherent to the thoracic wall in CT scans with indication to typing
Exclusion Criteria:
* Inability to provide free and informed consent, in the absence …
Contacts